<DOC>
	<DOCNO>NCT00545324</DOCNO>
	<brief_summary>In adult patient mild persistent asthma , singulair® 10 mg least effective low dose Inhaled Corticosteroids ( ICS ) improve asthma symptom control satisfaction 6 week comparison period .</brief_summary>
	<brief_title>First Step With Singulair® Therapy ( 0476-323 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>First time diagnosis mild asthma symptom require antiinflammatory controller medication Patients control short act beta2 agonist ( sab ) therapy ( require one treatment per week le 7 per week ) Patients dissatisfy low dose ic therapy , patient reluctant take ic therapy , patient insufficiently control due noncompliance low dose ic therapy precede 6 week Patient 's forced expiratory volume one second ( fev1 ) &lt; 80 % predict value Patient combination therapy Patient long act beta2 agonist Patient use moderate high dos ICS . ( ICS &gt; 250 &amp; micro g/day flovent &amp; reg ; equivalent per day )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>